Condition: Deep Venous Disease of the Lower Limbs · Sponsor: IRCCS San Raffaele
The European Venous Registry (EVeR) is an international repository of data on the treatments and outcomes of people with deep venous disease. The registry is designed to evaluate the outcomes of venous interventions over a ten-year period, with the ultimate goal to inform clinical decision making through the delivery of scientific evidence.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Department of Vascular Surgery | Marseille, France, France | Recruiting |
| European Venous Center | Aachen, Germany, Germany | Recruiting |
| Clinic of Vascular and Endovascular Surgery at Athens Medical Group | Athens, Greece, Greece | Recruiting |
| Interventional Radiology, Galway University Hospitals | Galway, Ireland, Ireland | Recruiting |
| IRCCS San Raffaele Hospital | Milan, Italy, Italy | Recruiting |
| Department of Vascular and Endovascular Surgery, Erasmus Medical Centre | Rotterdam, Netherlands, Netherlands | Recruiting |
| Vascular and Endovascular Department, Viamed Hospitals | Madrid, Spain, Spain | Recruiting |
| Department of Cardiovascular Surgery, Acibadem University School of Medicine, | Istanbul, Turkey, Turkey (Türkiye) | Recruiting |
| North Bristol NHS Trust | Bristol, United Kingdom, United Kingdom | Recruiting |
| St Thomas' Hospital | London, United Kingdom, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06906250